Fujifilm partners Peerless Hospital against breast cancer

Kolkata: Fujifilm India Pvt Ltd has joined hands with Peerless Hospital to take initiatives to battle breast cancer.

Peerless Hospital installed Fujifilm's 50 Micron digital Mammography machine which has redefined the way breast cancer is perceived in Kolkata. Its advanced technology enables better visualisation of the internal structure of the breast, thus making it possible to detect small breast lesions that may be difficult to detect in analogue mammography.

Fujifilm India Pvt Ltd in collaboration with the Peerless Hospital installed the state-of-the-art Amulet Innovality — a highly advanced breast cancer diagnostic machine that has made early detection of breast cancer a reality for women. To further support this cause, a symposium will be organised on clinical relevance of technology in addressing key challenges and solutions in breast imaging with digital mammography.

Amulet Innovality offer women a safe and personalised screening experience, making it easier for them to come for breast examinations. The Intelligent Automatic Exposure Control (i-AEC) defines the optimum X ray dosage for each breast type, compared to conventional AEC where the sensor position is fixed. Mammography is the most powerful breast cancer detection tool. Mammograms do not prevent breast cancer but they can save lives by finding breast cancers as early as possible. According to a report by WHO, Mammograms have been shown to reduce breast cancer mortality by around 20 percent in women by early detection.

A 2016 consensus document for breast cancer management by Indian Council of Medical Research says that more than 50 percent breast cancer patients are diagnosed too late. With an annual incidence of approximately 1,44,000 new cases of breast cancers in India, it has now become the most common female cancer in urban India. Breast cancer in India varies from as low as 5 per 100,000 female population per year in rural areas to 30 per 100,000 female population per year in urban areas.

Speaking on the occasion Yasunobu Nishiyama, Managing Director, Fujifilm India said: "It is a significant step in our fight against cancer. Breast cancer accounts for almost 27 percent of all cancer cases among women in India."